FALLS CHURCH, Va., Oct. 24, 2018 /PRNewswire-PRWeb/ -- FDA Data Integrity for Device and Pharma Firms, and Their Suppliers
FDA Data Integrity starts in one week.
FDA gives simple instructions to its investigators: "If initial findings indicate the firm's electronic records may not be trustworthy and reliable … a more detailed evaluation may be warranted."
That's the polite way of saying this is when to expect to receive a warning letter.
With the increased scrutiny on data integrity, establishing internal competency and assessment programs is essential.
Join award-winning FDA compliance expert, author and Cerulean founder John Avellanet for the interactive workshop: Data Integrity for Device and Pharma Firms, and Their Suppliers. He is recognized globally for his business-savvy pragmatic advice and engaging speaking style.
During the 10 workshop sessions, attendees will:
After two days of 'total immersion' study, attendees will return to their offices with increased understanding based on team exercises and case studies, informative, detailed explanations and honest no-holds-barred discussions with John and fellow attendees.
Reminder: FDA Data Integrity starts in one week.
Meet the Presenter: John Avellanet, Founder Cerulean Associates LLC
John Avellanet is an award-winning FDA compliance expert known for his business-savvy, pragmatic advice and engaging speaking style. Mr. Avellanet was the lead author of several certification courses on Good Manufacturing Practices (GMP) and Quality System Regulation (QSR) supplier management for the US Regulatory Affairs Professional Society.
Who Will Benefit:
Conference Details FDA Data Integrity for Device and Pharma Firms, and Their Suppliers **Presented by FDAnews and Cerulean Associates LLC ** Oct. 30-31, 2018 – San Francisco, CA http://www.fdanews.com/fdadataintegrity
Tuition: Regular Pricing: $1,797 Significant team discounts are available.
Easy Ways to Register Online: http://www.fdanews.com/fdadataintegrity By phone: 888-838-5578 or 703-538-7600
About FDAnews FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!